Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark

被引:147
作者
Skuladottir, H [1 ]
Olsen, JH [1 ]
机构
[1] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1200/JCO.2003.04.521
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose : The survival probability of patients with lung cancer is usually based on the extent of disease as assessed at the time of diagnosis. The discouraging 5-year survival is often reported (< 10%) without taking into account changes in the survival probability as time advances from diagnosis. Patients and Methods: Conditional survival estimates by sex, age, extent of disease, and histology were estimated for patients diagnosed with lung cancer in Denmark from 1943 to 1997. Survival probabilities were calculated by the Kaplan-Meier method, and cumulative survival estimates were used to derive conditional survival estimates. Results: For every additional year survived, the probability of surviving the next 5 years increases from 33% (men) and 36% (women) after the first year, to 60% (men) and 67% (women) who have survived 5 years. The 5-year survival probability of patients younger than 49 years who had survived the first year was 33%, and increased to 81% after the fifth year. Corresponding estimates for 60- to 69-year-old patients were 23% and 52%. The conditional survival differed greatly among patients with localized and regional disease (29% and 10%, respectively) in the first year, but converged with time (52% and 47%, respectively) after 5 years. The conditional survival is similar in patients with squamous cell carcinoma, adenocarcinoma, and large-cell carcinoma, but is markedly lower in patients with small-cell carcinoma. Conclusion: For patients who have survived more than 1 year, the conditional survival probability provides a more accurate estimate of survival as compared with the conventional observed survival rates.
引用
收藏
页码:3035 / 3040
页数:6
相关论文
共 11 条
[1]  
[Anonymous], INT CLASS DIS ONC
[2]   COMPUTED-TOMOGRAPHY TO STAGE LUNG-CANCER - APPROACHING A CONTROVERSY USING METAANALYSIS [J].
DALES, RE ;
STARK, RM ;
RAMAN, S .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (05) :1096-1101
[3]  
ENGELAND A, 1995, APMIS S49, V103, pS1
[4]   Variation in survival of patients with lung cancer in Europe, 1985-1989 [J].
Janssen-Heijnen, MLG ;
Gatta, G ;
Forman, D ;
Capocaccia, R ;
Coebergh, JWW .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (14) :2191-2196
[5]   Clinical significance of micrometastasis in lung and esophageal cancer: A new paradigm in thoracic oncology [J].
Jiao, XL ;
Krasna, MJ .
ANNALS OF THORACIC SURGERY, 2002, 74 (01) :278-284
[6]  
Kato I, 2001, CANCER, V92, P2211, DOI 10.1002/1097-0142(20011015)92:8<2211::AID-CNCR1565>3.0.CO
[7]  
2-W
[8]   Conditional survival among patients with carcinoma of the lung [J].
Merrill, RM ;
Henson, DE ;
Barnes, M .
CHEST, 1999, 116 (03) :697-703
[9]   Incidence of lung cancer in Denmark: historical and actual status [J].
Skuladottir, H ;
Olsen, JH ;
Hirsch, FR .
LUNG CANCER, 2000, 27 (02) :107-118
[10]  
Travis W., 1999, Histological Typing of Lung and Pleural Tumours